SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer ...

RIDGEFIELD, Conn., May 26, 2015 -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily STIOLTO™ RESPIMAT® (tiotropium bromide and olodaterol) ...

Tiotropium powder is supplied in capsules containing tiotropium 18 µg (as tiotropium bromide monohydrate) and lactose monohydrate (as the carrier). [5] Packages containing 6 or 30 capsules with one ...

Tiotropium as Asthma Add-On Treatment Shows Promise Boehringer Ingelheim announced that Spiriva Respimat (tiotropium bromide) Inhalation Spray is now available. The Respimat formulation uses ...

RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee ...

Please provide your email address to receive an email when new articles are posted on . Boehringer Ingelheim Pharmaceuticals announced that the FDA has agreed to review its new drug application for ...

In order to widen the narrowed airways in patients with chronic obstructive pulmonary disease (COPD), tiotropium bromide (tiotropium in brief) is one of the drugs available that can be prescribed for ...

BALTIMORE, Aug. 16, 2023 /PRNewswire/ -- Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin) today announced the launch of Tiotropium ...

June 15, 2011 — Patients using tiotropium via a mist inhaler for chronic obstructive pulmonary disease (COPD) have a 52% higher risk for all-cause mortality compared with placebo, according to a ...

Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and ...